CNX Therapeutics Ltd

Adalvo and its partner CNX Therapeutics have launched their extended-release formulation of pregabalin in the UK as a first in the major European market. News of the launch follows a slew of pregabali

Central nervous system specialist CNX Therapeutics and Alvo group B2B arm Adalvo are claiming a UK and European first, after introducing their prolonged-release formulation of generic nitrofurantoin i